{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:17:10Z","timestamp":1787926630860,"version":"build-2784847793"},"reference-count":50,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Am Psychiatr Nurses Assoc"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Opioid use disorder (OUD) continues to disproportionately impact rural communities. Telemental health (TMH) offers a promising strategy to bridge this divide, especially in the context of expanding telehealth-delivered medication for OUD (tele-MOUD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The purpose of this review was to examine the current evidence on TMH approaches for treating OUD among rural adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Databases including EMBASE, MEDLINE, CINAHL, PsycINFO, Scopus, the Cochrane Library, and ClinicalTrials.gov were searched in July 2024. Searches were updated in May and November 2025. All studies of TMH care for OUD in rural, adult populations were included. After eligibility screening, findings were synthesized from 23 empirical studies published between January 2022 and November 2025. Reviews published during the pandemic highlighted the need for research in this area. The quality of the evidence was assessed with the Mixed Methods Appraisal Tool (MMAT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In rural settings, TMH demonstrated greater access, retention, and patient satisfaction than traditional in-person care. Tele-mentoring expanded treatment capacity and supported provider confidence. However, disparities in broadband access, digital literacy, stigma, and organizational readiness hinder equitable implementation. Younger clients experienced lower retention, and low-income clients experienced limited access to video-based care. TMH was found to reduce public stigma, but stigma reduction education, particularly for frontline staff and pharmacies, is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Telemental health offers a scalable solution to rural OUD treatment inequities, but its success hinges on policy support, digital infrastructure investment, and culturallyresponsive, community-engaged implementation strategies. Future research should address long-term outcomes, standardized metrics, and broader innovations beyond tele-MOUD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10783903261473928","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:49:15Z","timestamp":1787726955000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Telemental Health Approaches for Rural Opioid Use Treatment: An Integrative Review"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5404-7362","authenticated-orcid":false,"given":"Jayme K.","family":"Weber","sequence":"first","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-5450","authenticated-orcid":false,"given":"Roxanne K.","family":"Vandermause","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","unstructured":"Anderson J. B. Martin S. A. Gadomski A. Krupa N. Mullin D. Cahill A. Jenkins P. (2022). Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes. Substance Abuse 43(1) 222\u2013230. https:\/\/doi.org\/10.1080\/08897077.2021.1931633","DOI":"10.1080\/08897077.2021.1931633"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"Anvari M. S. Sacko C. A. Atkinson G. E. Triplett N. S. Kihiuria M. W. Sonn M. S. Anane J. S. Derenoncourt M. Belcher A. M. Weintraub E. Kattakuzhy S. M. Magidson J. F. (2025). \u201cStigma is our most powerful enemy\u201d: Understanding opioid use disorder stigma and the role of peer support in rural Maryland. International Journal of Drug Policy 143 104924. https:\/\/doi.org\/10.1016\/j.drugpo.2025.10492","DOI":"10.1016\/j.drugpo.2025.104924"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","unstructured":"Appleton R. Williams J. Juan N. V. S. Needle J. J. Schlief M. Jordan H. Rains L. S. Goulding L. Badhan M. Roxburgh E. Barnett P. Spyridonidis S. Tomaskova M. Mo J. Harju-Sepp\u00e4nen J. Haime Z. Casetta C. Papamichail A. Lloyd-Evans B. . . . Johnson S. (2021). Implementation adoption and perceptions of telemental health during the COVID-19 pandemic: Systematic review. Journal of Medical Internet Research 23(12) Article e31746. https:\/\/doi.org\/10.2196\/31746","DOI":"10.2196\/31746"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Bahrami K. Kuo Y.-F. Digbeu B. Raji M. A. (2023). Association of medication-assisted therapy and risk of drug overdose-related hospitalization or emergency room visits in patients with opioid use disorder. Cureus 15(8) Article e44167. https:\/\/doi.org\/10.7759\/cureus.44167","DOI":"10.7759\/cureus.44167"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"Barnett P. Goulding L. Casetta C. Jordan H. Sheridan-Rains L. Steare T. Williams J. Wood L. Gaughran F. Johnson S. (2021). Implementation of telemental health services before COVID-19: Rapid umbrella review of systematic reviews. Journal of Medical Internet Research 23(7) Article e26492. https:\/\/doi.org\/10.2196\/26492","DOI":"10.2196\/26492"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","unstructured":"Belcher A. M. Kearley B. Kruis N. Rowland N. Spicyn N. Cole T. O. Welsh C. Fitzsimons H. McLean K. Weintraub E. (2024). Correlates of staff acceptability of a novel telemedicine-delivered medications for opioid use disorder program in a rural detention center. Journal of Correctional Health Care 30(4) 238\u2013244. https:\/\/doi.org\/10.1089\/jchc.23.11.0097","DOI":"10.1089\/jchc.23.11.0097"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Belcher A. M. Smith H. Welsh C. Fitzsimons H. Dalverny A. Lasher D. Coble K. Greenblatt A. D. Blue T. Gordon M. Weintraub E. (2025). Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine program. Drug and Alcohol Dependence 277 112950. https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112950","DOI":"10.1016\/j.drugalcdep.2025.112950"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","unstructured":"Brunet N. Moore D. T. Lendvai Wischik D. Mattocks K. M. Rosen M. I. (2022). Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Substance Abuse 43(1) 39\u201346. https:\/\/doi.org\/10.1080\/08897077.2020.1728466","DOI":"10.1080\/08897077.2020.1728466"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Casanova M. P. Nelson M. C. Blades K. C. Smith L. H. Seegmiller J. G. Baker R. T. (2022). Evaluation of an opioid and addiction treatment tele-education program for healthcare providers in a rural and frontier state. Journal of Opioid Management 18(4) 297\u2013308. https:\/\/doi.org\/10.5055\/jom.2022.0725","DOI":"10.5055\/jom.2022.0725"},{"key":"e_1_3_2_11_1","unstructured":"CDC. (2024 August 15). Addiction medicine toolkit. Overdose prevention. https:\/\/www.cdc.gov\/overdose-prevention\/hcp\/toolkits\/addiction-medicine.html"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","unstructured":"Chang J. E. Lindenfeld Z. Thomas T. Waldman J. Griffin J. (2022). Patient characteristics associated with phone versus video telemedicine visits for substance use treatment during COVID-19. Journal of Addiction Medicine 16(6) 659\u2013665. https:\/\/doi.org\/10.1097\/ADM.0000000000000985","DOI":"10.1097\/ADM.0000000000000985"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Chen H. Knettel B. A. Macon Harrison L. Des Marais A. Nelli A. Campbell H. A. Muhirwa A. McKellar M. S. Gulur P. Guthrie S. (2023). Leveraging policy changes made in response to COVID-19 to advance telehealth and novel treatment approaches for people who use opioids: Qualitative perspectives from two rural North Carolina counties. North Carolina Medical Journal 84(5) 335\u2013341. https:\/\/doi.org\/10.18043\/001c.83930","DOI":"10.18043\/001c.83930"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Ciccarone D. (2019). The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. International Journal of Drug Policy 71 183\u2013188. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010","DOI":"10.1016\/j.drugpo.2019.01.010"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Ciccarone D. (2021). The rise of illicit fentanyls stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry 34(4) 344\u2013350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717","DOI":"10.1097\/YCO.0000000000000717"},{"key":"e_1_3_2_16_1","unstructured":"Consolidated Appropriations Act 2023 Pub. L. No. 117-328 136 Stat. 4459 (2022). https:\/\/www.congress.gov\/bill\/117th-congress\/house-bill\/2617"},{"key":"e_1_3_2_17_1","unstructured":"Drug Enforcement Administration. (2024 November 19). Third temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Federal Register. https:\/\/www.federalregister.gov\/documents\/2024\/11\/19\/2024-27018\/third-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Garcia G. (2025). The role of AI in transforming psychiatric-mental health care: Enhancing the role of psychiatric-mental health nurse practitioners. Nursing Outlook 73(4) Article 102461. https:\/\/doi.org\/10.1016\/j.outlook.2025.102461","DOI":"10.1016\/j.outlook.2025.102461"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Garnett M. F. Mini\u00f1o A. M. (2024 December 17). Drug overdose deaths in the United States 2003-2023. https:\/\/doi.org\/10.15620\/cdc\/170565","DOI":"10.15620\/cdc\/170565"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","unstructured":"Hendy L. E. Hill L. G. Olguin A. Barrett E. Jimes C. Coffey M. J. Lira M. C. (2025). Pharmacy barriers to receiving buprenorphine among patients undergoing telemedicine addiction treatment. JAMA Network Open 8(8) e2527418. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.27418","DOI":"10.1001\/jamanetworkopen.2025.27418"},{"key":"e_1_3_2_21_1","author":"Hong Q. N.","year":"2018","unstructured":"Hong Q. N., Pluye P., F\u00e0bregues S., Bartlett G., Boardman F., Cargo M., Dagenais P., Gagnon M.-P., Griffiths F., Nicolau B., O\u2019Cathain A., Rousseau M.-C., Vedel I. (2018). Mixed Methods Appraisal Tool (MMAT). Registration of Copyright (#1148552), Canadian Intellectual Property Office, Industry Canada.","journal-title":"Mixed Methods Appraisal Tool (MMAT)"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","unstructured":"Hser Y.-I. Mooney L. J. Baldwin L.-M. Ober A. Marsch L. A. Sherman S. Matthews A. Clingan S. Fei Z. Zhu Y. Dopp A. Curtis M. E. Osterhage K. P. Hichborn E. G. Lin C. Black M. Calhoun S. Holtzer C. C. Nesin N. . . . Saxon A. J. (2023). Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm multisite feasibility study. The Journal of Rural Health\u202f: Official Journal of the American Rural Health Association and the National Rural Health Care Association 39(4) 780\u2013788. https:\/\/doi.org\/10.1111\/jrh.12760","DOI":"10.1111\/jrh.12760"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","unstructured":"Jayathilake A. Hodgson K. Mansoor M. Markel K. Bardwell G. (2025). The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia Canada. Harm Reduction Journal 22(1) 164. https:\/\/doi.org\/10.1186\/s12954-025-01302-z","DOI":"10.1186\/s12954-025-01302-z"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Johnson E. A. Strauch K. A. (2023). A mixed-methods pilot examination of Montana North Dakota nurse practitioner telepresence behaviors through web-camera eye-tracking and qualitative descriptive interviews. Journal of the American Association of Nurse Practitioners 36(5) 270\u2013278. https:\/\/doi.org\/10.1097\/JXX.0000000000000974","DOI":"10.1097\/JXX.0000000000000974"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","unstructured":"Katz C. Ruiz J. M. Saig\u00ed-Rubi\u00f3 F. Novillo-Ortiz D. (2025). The state of the art of telemedicine implementation architecture: Rapid umbrella review of systematic reviews. Journal of Medical Internet Research 27(1) e70276. https:\/\/doi.org\/10.2196\/70276","DOI":"10.2196\/70276"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","unstructured":"Krawczyk N. Rivera B. D. King C. Dooling B. C. E. (2023). Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the United States. Health Affairs Scholar 1(1) Article qxad013. https:\/\/doi.org\/10.1093\/haschl\/qxad013","DOI":"10.1093\/haschl\/qxad013"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","unstructured":"Langarizadeh M. Tabatabaei M. S. Tavakol K. Naghipour M. Rostami A. Moghbeli F. (2017). Telemental health care an effective alternative to conventional mental care: A systematic review. Acta Informatica Medica 25(4) 240\u2013246. https:\/\/doi.org\/10.5455\/aim.2017.25.240-246","DOI":"10.5455\/aim.2017.25.240-246"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","unstructured":"Lin C. Zhu Y. Mooney L. J. Ober A. Clingan S. E. Baldwin L.-M. Calhoun S. Hser Y.-I. (2024). Referral of patients from rural primary care clinics to telemedicine vendors for opioid use disorder treatment: A mixed-methods study. Journal of Telemedicine and Telecare 31 832\u2013841. https:\/\/doi.org\/10.1177\/1357633X231226261","DOI":"10.1177\/1357633X231226261"},{"key":"#cr-split#-e_1_3_2_29_1.1","doi-asserted-by":"crossref","unstructured":"Lira M. C. Jimes C. Coffey M. J. (2023). Retention in telehealth treatment for opioid use disorder among rural populations: A retrospective cohort study. Telemedicine Journal and E-Health 29","DOI":"10.1089\/tmj.2023.0044"},{"key":"#cr-split#-e_1_3_2_29_1.2","doi-asserted-by":"crossref","unstructured":"(12) 1890. https:\/\/doi.org\/10.1089\/tmj.2023.0044","DOI":"10.1089\/tmj.2023.0044"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","unstructured":"Lister J. J. Weaver A. Ellis J. D. Himle J. A. Ledgerwood D. M. (2020). A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. The American Journal of Drug and Alcohol Abuse 46(3) 273\u2013288. https:\/\/doi.org\/10.1080\/00952990.2019.1694536","DOI":"10.1080\/00952990.2019.1694536"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","unstructured":"Marshall S. A. Siebenmorgen L. E. Youngen K. Borders T. Zaller N. (2024). Primary care providers\u2019 experiences treating opioid use disorder using telehealth in the height of the COVID-19 pandemic. Journal of Primary Care & Community Health 15 Article 21501319241246359. https:\/\/doi.org\/10.1177\/21501319241246359","DOI":"10.1177\/21501319241246359"},{"issue":"1","key":"e_1_3_2_32_1","first-page":"87","article-title":"Factors in utilization of telehealth treatment by rural African-Americans with opioid use disorder and disabilities","volume":"88","author":"McCray S. H.","year":"2022","unstructured":"McCray S. H., Uhunoma O., Starr R., Manyibe E. O., Ole Koissaba B. R., Ward-Sutton C., Lewis A. N., Moore C. L. (2022). Factors in utilization of telehealth treatment by rural African-Americans with opioid use disorder and disabilities. Journal of Rehabilitation, 88(1), 87\u201395.","journal-title":"Journal of Rehabilitation"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","unstructured":"Michero D. Monico L. Pielsticker P. Mooney L. J. Glasner S. (2025). Concurrent treatment of opioid and tobacco use disorder in a telemedicine clinic: Case report of breaking through barriers. JMIR Formative Research 9(1) Article e72872. https:\/\/doi.org\/10.2196\/72872","DOI":"10.2196\/72872"},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","unstructured":"Nazemi M. Kiani S. Zakerabasali S. (2023). Tele-mental health during the COVID-19 pandemic: A systematic review of the literature focused on technical aspects and challenges. Health Science Reports 6(10) Article e1637. https:\/\/doi.org\/10.1002\/hsr2.1637","DOI":"10.1002\/hsr2.1637"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","unstructured":"Nguyen B. Zhao C. Bailly E. Chi W. (2024). Telehealth initiation of buprenorphine for opioid use disorder: Patient characteristics and outcomes. Journal of General Internal Medicine 39(1) 95\u2013102. https:\/\/doi.org\/10.1007\/s11606-023-08383-1","DOI":"10.1007\/s11606-023-08383-1"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","unstructured":"Ober A. J. Dopp A. R. Clingan S. E. Curtis M. E. Lin C. Calhoun S. Larkins S. Black M. Hanano M. Osterhage K. P. Baldwin L.-M. Saxon A. J. Hichborn E. G. Marsch L. A. Mooney L. J. Hser Y.-I. (2024). Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics. Journal of Substance Use & Addiction Treatment 156 Article 209194. https:\/\/doi.org\/10.1016\/j.josat.2023.209194","DOI":"10.1016\/j.josat.2023.209194"},{"key":"e_1_3_2_37_1","doi-asserted-by":"crossref","unstructured":"Page M. J. McKenzie J. E. Bossuyt P. M. Boutron I. Hoffmann T. C. Mulrow C. D. Shamseer L. Tetzlaff J. M. Akl E. A. Brennan S. E. Chou R. Glanville J. Grimshaw J. M. Hr\u00f3bjartsson A. Lalu M. M. Li T. Loder E. W. Mayo-Wilson E. McDonald S. . . . Moher D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372 Article n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","unstructured":"Patel S. Y. Huskamp H. A. Busch A. B. Mehrotra A. (2020). Telemental health and us rural\u2013urban differences in specialty mental health use 2010\u20132017. American Journal of Public Health 110(9) 1308\u20131314. https:\/\/doi.org\/10.2105\/AJPH.2020.305657","DOI":"10.2105\/AJPH.2020.305657"},{"key":"e_1_3_2_39_1","doi-asserted-by":"crossref","unstructured":"Pham H. Ober A. Baldwin L.-M. Mooney L. J. Zhu Y. Fei Z. Hser Y.-I. (2024). Social determinants of health and continuity of medications for opioid use disorder among patients receiving treatment in rural primary care settings. Journal of Addiction Medicine 18(3) 331\u2013334. https:\/\/doi.org\/10.1097\/ADM.0000000000001274","DOI":"10.1097\/ADM.0000000000001274"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","unstructured":"Philippe T. J. Sikder N. Jackson A. Koblanski M. E. Liow E. Pilarinos A. Vasarhelyi K. (2022). Digital health interventions for delivery of mental health care: systematic and comprehensive meta-review. JMIR Mental Health 9(5) Article e35159. https:\/\/doi.org\/10.2196\/35159","DOI":"10.2196\/35159"},{"key":"e_1_3_2_41_1","doi-asserted-by":"crossref","unstructured":"Pro G. Cantor J. Willis D. Gu M. Fairman B. Baloh J. Montgomery B. E. (2024). A multilevel analysis of changing telehealth availability in opioid use disorder treatment settings: Conditional effects of rurality the number and types of medication for opioid use disorder available and time US 2016\u20132023. University of Nebraska Medical Center. Retrieved October 15 2024 from https:\/\/unmc.primo.exlibrisgroup.com","DOI":"10.1111\/jrh.12854"},{"key":"e_1_3_2_42_1","doi-asserted-by":"crossref","unstructured":"Schlief M. Saunders K. R. K. Appleton R. Barnett P. Vera San Juan N. Foye U. Olive R. R. Machin K. Shah P. Chipp B. Lyons N. Tamworth C. Persaud K. Badhan M. Black C.-A. Sin J. Riches S. Graham T. Greening J. . . . Johnson S. (2022). Synthesis of the evidence on what works for whom in telemental health: rapid realist review. Interactive Journal of Medical Research 11(2) Article e38239. https:\/\/doi.org\/10.2196\/38239","DOI":"10.2196\/38239"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","unstructured":"Teck J. T. W. Zlatkute G. Perez A. Dritschel H. Ghosh A. Potenza M. N. Ambekar A. Ekhtiari H. Stein D. Khazaal Y. Arunogiri S. Torrens M. Ferri M. Galea-Singer S. Baldacchino A. (2023). Key implementation factors in telemedicine-delivered medications for opioid use disorder: A scoping review informed by normalisation process theory. The Lancet Psychiatry 10(1) 50\u201364. https:\/\/doi.org\/10.1016\/S2215-0366(22)00374-1","DOI":"10.1016\/S2215-0366(22)00374-1"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","unstructured":"Textor L. Ventricelli D. Aronowitz S. V. (2022). \u201cRed Flags\u201d and \u201cRed Tape\u201d: Telehealth and pharmacy-level barriers to buprenorphine in the United States. The International Journal on Drug Policy 105 103703. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103703","DOI":"10.1016\/j.drugpo.2022.103703"},{"key":"e_1_3_2_45_1","doi-asserted-by":"crossref","unstructured":"Valizadeh A. Moassefi M. Nakhostin-Ansari A. Hosseini Asl S. H. Saghab Torbati M. Aghajani R. Maleki Ghorbani Z. Faghani S. (2022). Abstract screening using the automated tool Rayyan: Results of effectiveness in three diagnostic test accuracy systematic reviews. BMC Medical Research Methodology 22 160. https:\/\/doi.org\/10.1186\/s12874-022-01631-8","DOI":"10.1186\/s12874-022-01631-8"},{"key":"e_1_3_2_46_1","doi-asserted-by":"crossref","unstructured":"Watanabe J. Teraura H. Nakamura A. Kotani K. (2023). Telemental health in rural areas: A systematic review. Journal of Rural Medicine: JRM 18(2) 50\u201354. https:\/\/doi.org\/10.2185\/jrm.2022-059","DOI":"10.2185\/jrm.2022-059"},{"key":"e_1_3_2_47_1","doi-asserted-by":"crossref","unstructured":"Watson D. P. Phalen P. Medcalf S. Messmer S. McGuire A. (2023). Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services. Substance Abuse Treatment Prevention and Policy 18(1) 9. https:\/\/doi.org\/10.1186\/s13011-023-00523-4","DOI":"10.1186\/s13011-023-00523-4"},{"key":"e_1_3_2_48_1","doi-asserted-by":"crossref","unstructured":"Weiss C. R. Roberts M. Florell M. Wood R. Johnson-Koenke R. Amura C. R. Kissler K. Barton A. J. Jones J. (2024). Best practices for telehealth in nurse-led care settings\u2014a qualitative study. Policy Politics & Nursing Practice 25(1) 47\u201357. https:\/\/doi.org\/10.1177\/15271544231201417","DOI":"10.1177\/15271544231201417"},{"key":"e_1_3_2_49_1","doi-asserted-by":"crossref","unstructured":"Whittemore R. Knafl K. (2005). The integrative review: Updated methodology. Journal of Advanced Nursing 52(5) 546\u2013553. https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/j.1365-2648.2005.03621.x","DOI":"10.1111\/j.1365-2648.2005.03621.x"},{"key":"e_1_3_2_50_1","doi-asserted-by":"crossref","unstructured":"Williams A. R. Aronowitz S. V. Rowe C. Gallagher R. Behar E. Bisaga A. (2023). Telehealth for opioid use disorder: Retention as a function of demographics and rurality. American Journal of Drug & Alcohol Abuse 49(2) 260\u2013265. https:\/\/doi.org\/10.1080\/00952990.2023.2180382","DOI":"10.1080\/00952990.2023.2180382"}],"container-title":["Journal of the American Psychiatric Nurses Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10783903261473928","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10783903261473928","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10783903261473928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:17:30Z","timestamp":1787923050000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10783903261473928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":50,"alternative-id":["10.1177\/10783903261473928"],"URL":"https:\/\/doi.org\/10.1177\/10783903261473928","relation":{},"ISSN":["1078-3903","1532-5725"],"issn-type":[{"value":"1078-3903","type":"print"},{"value":"1532-5725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"10783903261473928"}}